Bladder cancer recurrence: Part II. What do I tell my patients about lifestyle changes and dietary supplements?

被引:6
作者
Moyad, MA [1 ]
机构
[1] Univ Michigan, Med Ctr, Dept Urol, Ann Arbor, MI 48109 USA
关键词
alternative medicine; bladder cancer; complementary medicine; dietary supplements; lifestyle changes; prevention; recurrence;
D O I
10.1097/00042307-200309000-00004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The purpose of this review is to provide the clinician with an adequate summary of current potential recommendations for reducing the risk of bladder cancer recurrence so that this topic can be discussed with patients that are dealing with this specific situation. Recent findings Several potential novel methods to reduce the risk of recurrence should be discussed with patients. Non-selective and selective cyclo-oxygenase 2 inhibitors have preliminary data from from laboratory and epidemiologic investigations. Several preliminary trials have found that a combination dietary supplement of vitamins and minerals or a probiotic agent (Lactobacillus casei) may impact recurrence rates. Smoking cessation may be one of the best routes for reducing recurrence and reducing the risk of overall early morbidity and mortality. Garlic or fluid intake need more clinical data. Summary Clinical recommendations for reducing the risk of bladder cancer recurrence need more attention. Preliminary data seem to support a potential role of numerous lifestyle and dietary supplement regimens. In the future, more reviews on the potential impact of reducing recurrence should be separated from reviews on prevention because these can be confusing when treated as a single subject.
引用
收藏
页码:379 / 383
页数:5
相关论文
共 48 条
  • [1] Herbal medicines and perioperative care
    Ang-Lee, MK
    Moss, J
    Yuan, CS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02): : 208 - 216
  • [2] [Anonymous], 1997, WORLD HTLH REP
  • [3] PROPHYLACTIC EFFECT OF A LACTOBACILLUS-CASEI PREPARATION ON THE RECURRENCE OF SUPERFICIAL BLADDER-CANCER
    ASO, Y
    AKAZAN, H
    [J]. UROLOGIA INTERNATIONALIS, 1992, 49 (03) : 125 - 129
  • [4] PREVENTIVE EFFECT OF A LACTOBACILLUS-CASEI PREPARATION ON THE RECURRENCE OF SUPERFICIAL BLADDER-CANCER IN A DOUBLE-BLIND TRIAL
    ASO, Y
    AKAZA, H
    KOTAKE, T
    TSUKAMOTO, T
    IMAI, K
    NAITO, S
    [J]. EUROPEAN UROLOGY, 1995, 27 (02) : 104 - 109
  • [5] Does smoking status influence the prognosis of bladder cancer? A systematic review
    Aveyard, P
    Adab, P
    Cheng, KK
    Wallace, DMA
    Hey, K
    Murphy, MFG
    [J]. BJU INTERNATIONAL, 2002, 90 (03) : 228 - 239
  • [6] A randomized trial of aspirin to prevent colorectal adenomas
    Baron, JA
    Cole, BF
    Sandler, RS
    Haile, RW
    Ahnen, D
    Bresalier, R
    McKeown-Eyssen, G
    Summers, RW
    Rothstein, R
    Burke, CA
    Snover, DC
    Church, TR
    Allen, JI
    Beach, M
    Beck, GJ
    Bond, JH
    Byers, T
    Greenberg, ER
    Mandel, JS
    Marcon, N
    Mott, LA
    Pearson, L
    Saibil, F
    van Stolk, RU
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (10) : 891 - 899
  • [7] BYAR D, 1977, Urology, V10, P556, DOI 10.1016/0090-4295(77)90101-7
  • [8] CASE RAM, 1993, BRIT J IND MED, V50, P389
  • [9] Castelao JE, 2000, BRIT J CANCER, V82, P1364
  • [10] Cheng AL, 2001, ANTICANCER RES, V21, P2895